NEW YORK, NY -- (MARKET WIRE) -- April 26, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced that Dr. Joseph Feldschuh, President & CEO, Stephen Feldschuh, Chief Operating Officer, & and John Reyes-Guerra, VP for Sales and Marketing, will be participating with 12 other companies in the exclusive Taglich Brothers Small Cap Equity Conference at 2:15 p.m. on May 1, 2007. The event will be held at Le Parker Meridien, New York City, where institutional investors will obtain insight into the small-cap sector through direct interaction with company management teams.

More information about the conference can be found at: www.taglich.com.

About Daxor

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a trial basis are The Mayo Clinic, The Cleveland Clinic and New York University Medical Center

For More Information Contact:

For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com, or contact Stephen Feldschuh, 212-330-8515 (VP of Operations) stephen@daxor.com or Diane Meegan, 212-330-8512 (Investor Relations) dmeegan@daxor.com.

Contact Information: Contact: Stephen Feldschuh 212-330-8515 VP of Operations Email Contact Diane Meegan 212-330-8512 Investor Relations Email Contact